Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded new related topics entries to the study page: 'Multiple myeloma' and 'MedlinePlus Genetics', enhancing cross-references and context on the record.SummaryDifference0.1%

- Check20 days agoChange DetectedA bibliographic citation entry related to multiple myeloma risk/progression is adjusted, and the page’s displayed site revision/version is updated from v3.5.2 to v3.5.3. These updates reflect general page content organization and site release metadata rather than changes to the clinical study itself.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a related topic MedlinePlus Genetics and a new reference to the Lancet Oncology paper with revision v3.5.0; the prior Erratum entry for that paper (v3.4.3) was removed.SummaryDifference0.2%

- Check63 days agoChange DetectedExpanded indexing terms and metadata have been added to the page, including MeSH terms and record history details.SummaryDifference84%

- Check70 days agoChange DetectedRevision: v3.4.3 was added to the page. No substantive study details or eligibility criteria appear to have changed.SummaryDifference21%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.